Background An open-label study indicated that selective depletion of B cells with the use of
rituximab led to sustained clinical improvements for patients with rheumatoid arthritis. To …

Background Despite rapid growth in eHealth research, there remains a lack of consistency
in defining and using terms related to eHealth. More widely cited definitions provide broad …

Background: Angiotensin converting enzyme (ACE) 2 is a recently identified homologue of
ACE that may counterregulate the actions of angiotensin (Ang) II by facilitating its breakdown …

Objective To determine the efficacy and safety of treatment with rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …

Objective To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX),
with or without glucocorticoids, in patients with active rheumatoid arthritis (RA) …

Objective To evaluate the long-term safety profile for upadacitinib across rheumatoid
arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and atopic dermatitis (AD). …

Besides interferon, only two drugs—lamivudine and adefovir dipivoxil—are approved as first-line
therapy for chronic hepatitis B (CHB) in the EU [1, 2]. Each is a nucleoside or …

Objective. To evaluate the efficacy and safety of three dosing and repeat treatment regimens
of rituximab (RTX) plus MTX in patients with active RA. Methods. Patients with active RA …

Objective: To determine if treatment with a B cell-targeted therapy can inhibit the progression
of structural joint damage in patients with rheumatoid arthritis (RA), exhibiting an …

Gold nanorods of different aspect ratios are prepared using the growth‐directing surfactant,
cetyltrimethylammonium bromide (CTAB), which forms a bilayer on the gold nanorod surface…